Roxadustat (Ai RuiZhuo® in China) is the first oral drug in its class and a potent HIF-PHD inhibitor used to treat anemia in CKD patients not on dialysis and on dialysis, as well as in myelodysplastic syndromes. This evidence concerns the gene PDC and anemia.